We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





The COVID-19 Pandemic: Primed and Prepared

By CLN Stat
Posted on 14 Dec 2020
Print article
Illustration
Illustration
Late-breaking scientific sessions detail the testing and response landscape, latest science on SARS-CoV-2 virology and therapeutics, quest for vaccines, more effective mobilization against new global health threats.

Seven late-breaking sessions at the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo address the game-changing topic of SARS-CoV-2, exploring the virology and characteristics of this novel virus and the recent landscape of testing and therapeutics. “Each of these scientific sessions will provide attendees a much deeper understanding of the COVID-19 pandemic and shed light on the advantages and disadvantages of the various tests that are being performed for SARS-CoV-2, from molecular to serology,” Paul Jannetto, PhD, DABCC, FAACC, chair of the Annual Meeting Organizing Committee (AMOC), told CLN Stat.

Participants will gain a deeper comprehension of how this virus differs from others and of current treatment strategies.

The postponement of the 2020 Annual Scientific Meeting & Clinical Lab Expo from July to December underscored the importance of providing the latest scientific information on the COVID-19 pandemic, said Jannetto. AMOC wanted to highlight timely and novel research on antibody/antigen testing, therapeutic strategies, and the latest information about a vaccine against SARS-CoV-2.

The panel also wanted to include a general session on virology and diagnostic paradigms, supply chain and laboratory testing issues, and the role of clinical labs in global pandemics. “As a result, the AMOC actively recruited experts in each of these areas who graciously agreed to provide attendees the cutting-edge scientific information around each of these relevant topics,” said Jannetto.

In a special session on Tuesday, December 15, Assistant Secretary of Health Adm. Brett P. Giroir, MD, who coordinates SARS-CoV-2 testing efforts across the Department of Health and Human Services, will discuss the past, present, and future of SARS-CoV-2. This session will take place from 4:30–5:30 p.m. (U.S. Central Standard Time)

Jannetto is also looking forward to the Chair’s Invited Session this year, Pandemic Preparedness: The Role of Clinical Laboratories and Public Health in Controlling Outbreaks Representing a Global Health Threat. His colleague Matthew Binnicker, PhD, director of clinical virology at Mayo Clinic, will be talking about the role of clinical labs and public health in controlling global outbreaks and what laboratories can do to be better prepared for the next pandemic. This presentation takes place on Monday, December 14, from 11 a.m.–12:30 p.m.

Related Links:
2020 AACC Annual Scientific Meeting & Clinical Lab Expo
Annual Meeting Organizing Committee
Pandemic Preparedness: The Role of Clinical Laboratories and Public Health in Controlling Outbreaks Representing a Global Health Threat
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.